SCHEMBL34512

SCHEMBL34512

Cc1cc(C)c(N2C=CN(c3c(C)cc(C)cc3C)C2)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RAPGEF4 Q8WZA2 3/20 0.35
KDM4E B2RXH2 3/20 0.34
HRH3 Q9Y5N1 1/20 0.32
SELL P14151 1/20 0.31
SELP P16109 1/20 0.31
SELE P16581 1/20 0.31
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL552835 0.98 ALDH1A1 (0.34) ALDH1A1NPSR1MAPTPOLBHTT
Bromide SCHEMBL30353850 0.98 ALDH1A1 (0.34) ALDH1A1NPSR1MAPTPOLBHTT
Iodide SCHEMBL28719252 0.98 ALDH1A1 (0.34) ALDH1A1NPSR1MAPTPOLBHTT
Bromide SCHEMBL6890023 0.95 ALDH1A1 (0.33) ALDH1A1NPSR1MAPTPOLBHTT
SCHEMBL31364278 0.91 ALDH1A1 (0.32) ALDH1A1NPSR1MAPTPOLBHTT
Bicarbonate SCHEMBL26607952 0.89 KDM4E (0.41) ALDH1A1NPSR1MAPTPOLBHTT
SCHEMBL17532969 0.87 HRH3 (0.32) ALDH1A1NPSR1MAPTPOLBHTT
SCHEMBL25934333 0.86 RAPGEF4 (0.37) RAPGEF4HRH3
SCHEMBL18538762 0.84 NPSR1 (0.40) ALDH1A1NPSR1MAPTPOLBHTT
SCHEMBL27913544 0.84 MAPT (0.38) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1653 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026535-B1 BIODEGRADABLE COPOLYMERS FOR COSMETIC USE INTERCOS ITALIANA (IT) 2025-07-09 EP claimed
WO-2025034579-A1 METHODS FOR PREPARATION OF BIOCOMPATIBLE SOLUTIONS WITH SABRE HYPERPOLARIZATION VIZMA LIFE SCIENCES, INC. (US) 2025-02-13 WO claimed
CN-114533593-B Cosmetic in the form of a liquid paste at normal temperature and composition of biodegradable copolymers 莹特丽股份公司 2024-06-25 CN claimed
EP-3016991-B1 LIQUID MOLDING COMPOSITIONS MATERIA INC (US) 2024-06-12 EP claimed
EP-4139281-B1 SULFUR EXTRUSION FROM DISULFIDES BY CARBENES UNIV HEIDELBERG (DE) 2024-05-08 EP claimed
WO-2024086429-A1 POLYMER FIBERS AND PARTICLES PRODUCED BY ELECTROSPINNING OR ELECTROSPRAYING SCALE HOLDINGS LLC (US) 2024-04-25 WO claimed
CN-117486672-A Method for synthesizing fluorobenzene from sulfur hexafluoride 国网安徽省电力有限公司电力科学研究院 2024-02-02 CN claimed
CN-112625502-B Ink composition, quantum dot-polymer composite, display device, and method of manufacturing the same 三星显示有限公司 2024-01-19 CN claimed
EP-3256505-B1 CYCLIC OLEFIN RESIN COMPOSITIONS COMPRISING FUNCTIONAL ELASTOMERS MATERIA INC (US) 2023-11-29 EP claimed
US-11821112-B1 Polymer fibers and particles produced by electrospinning or electrospraying SCALE HOLDINGS LLC (US) 2023-11-21 US claimed
US-7001590-B1 Metathesis-curable composition KERR CORPORATION (US) 2006-02-21 US claimed
WO-2005121158-A1 TRANSITION METAL CARBENE COMPLEXES CONTAINING A CATIONIC SUBSTITUENT AS CATALYSTS OF OLEFIN METATHESIS REACTIONS UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2005-12-22 WO claimed
WO-2005063834-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2005-07-14 WO claimed
US-20050137369-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2005-06-23 US claimed
US-20050131233-A1 Ruthenium compounds, their production and use UNIVERSITY OF OTTAWA (CA) 2005-06-16 US claimed
US-RE38676-E1 Metathesis ring opening polymerization (\"ROMP\"); catalysis, addition polymerization; molding polymers with extended pot-lives CALIFORNIA INSTITUTE OF TECHNOLOGY 2004-12-21 US claimed
US-20040254320-A1 Metathesis-curable composition with a reaction control agent KERR CORPORATION 2004-12-16 US claimed
US-6774274-B2 CATIONIC IRIDIUM CARBENE COMPLEXES; HYDROGENATION CATALYSTS CAPABLE OF HYDROGENATING SIMPLE OLEFINS AT ROOM TEMPERATURE UNIVERSITY OF NEW ORLEANS RESEARCH AND TECHNOLOGY FOUNDATION, INC. 2004-08-10 US claimed
US-20020173650-A1 Metal complexes for hydrogenation of unsaturated compounds UNIVERSITY OF NEW ORLEANS RESEARCH AND TECHNOLOGY FOUNDATION, INC. 2002-11-21 US claimed
US-6107420-A ADDING CATALYST TO REACTION SOLUTION WITH EXTENDED POT LIFE AT FIRST TEMPERATURE, HEATING TO SECOND TEMPERATURE TO INITIATE METATHESIS RING OPENING POLYMERIZATION CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-08-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131233-A1 Ruthenium compounds, their production and use TIPARP, SPR, PARP14 ALDH1A1 775/4885NPSR1 3265/4885MAPT 3504/4885
US-20020173650-A1 Metal complexes for hydrogenation of unsaturated compounds INTS6, PRDX6, PRDX2 ALDH1A1 4377/4885NPSR1 2843/4885MAPT 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.